This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Abbott Japan LLC, Abbott Japan Co. Ltd., Abbott Laboratories Corporation. Active years: 2015-2022.
Location History:
- Kashiwa, JP (2015)
- Chiba, JP (2018)
- Tokyo, JP (2022)
Company Filing History:
2 out of 5 
1 out of 6 
1 out of 4,186 
Years Active: 2015-2022
Title: The Innovative Contributions of Eisaku Yoshida
Introduction
Eisaku Yoshida is a notable inventor based in Chiba, Japan, recognized for his significant contributions to the field of medical diagnostics. With a total of three patents to his name, Yoshida has focused on developing methods that enhance the diagnosis and monitoring of serious health conditions.
Latest Patents
Yoshida's latest patents include groundbreaking methods for diagnosing hepatocellular carcinoma and pancreatic cancer. These patents disclose biomarkers such as laminin gamma 2 monomer, PIVKA-II, AFP, CEA, and CA19-9, which can be used to diagnose, prognose, classify risk, and monitor the progression of these cancers. Additionally, he has developed immunoassay methods and reagents aimed at reducing nonspecific binding in tests for PIVKA-II, utilizing various additives to improve accuracy.
Career Highlights
Throughout his career, Yoshida has worked with prominent companies, including Abbott Japan LLC and Abbott Laboratories Corporation. His work has significantly impacted the field of cancer diagnostics, showcasing his commitment to advancing medical technology.
Collaborations
Yoshida has collaborated with esteemed colleagues such as Toru Yoshimura and Barry Lee Dowell, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Eisaku Yoshida's innovative work in medical diagnostics exemplifies the vital role of inventors in advancing healthcare technology. His contributions continue to influence the methods used in diagnosing critical diseases, ultimately benefiting patient care.